BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12888534)

  • 1. General plasmids for producing RNA in vitro transcripts with homogeneous ends.
    Walker SC; Avis JM; Conn GL
    Nucleic Acids Res; 2003 Aug; 31(15):e82. PubMed ID: 12888534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cis-acting ribozymes for the production of RNA in vitro transcripts with defined 5' and 3' ends.
    Avis JM; Conn GL; Walker SC
    Methods Mol Biol; 2012; 941():83-98. PubMed ID: 23065555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotranscriptional 3'-End Processing of T7 RNA Polymerase Transcripts by a Smaller HDV Ribozyme.
    Akoopie A; Müller UF
    J Mol Evol; 2018 Aug; 86(7):425-430. PubMed ID: 30099590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel RNA-transcript-trimming plasmid which can be used both in vitro in place of run-off and (G)-free transcriptions and in vivo as multi-sequences transcription vectors.
    Taira K; Nakagawa K; Nishikawa S; Furukawa K
    Nucleic Acids Res; 1991 Oct; 19(19):5125-30. PubMed ID: 1923797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template.
    von Weizsäcker F; Blum HE; Wands JR
    Biochem Biophys Res Commun; 1992 Dec; 189(2):743-8. PubMed ID: 1472046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans-acting antigenomic HDV ribozyme for production of in vitro transcripts with homogenous 3' ends.
    Szafraniec M; Blaszczyk L; Wrzesinski J; Ciesiolka J
    Methods Mol Biol; 2012; 941():99-111. PubMed ID: 23065556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal method to produce in vitro transcripts with homogeneous 3' ends.
    Schürer H; Lang K; Schuster J; Mörl M
    Nucleic Acids Res; 2002 Jun; 30(12):e56. PubMed ID: 12060694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA synthesis: strategies for the use of bacteriophage RNA polymerases.
    Krupp G
    Gene; 1988 Dec; 72(1-2):75-89. PubMed ID: 2468576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus.
    Belinsky MG; Dinter-Gottlieb G
    Nucleic Acids Res; 1991 Feb; 19(3):559-64. PubMed ID: 2011528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating in vitro transcripts with homogenous 3' ends using trans-acting antigenomic delta ribozyme.
    Wichlacz A; Legiewicz M; Ciesiołka J
    Nucleic Acids Res; 2004 Feb; 32(3):e39. PubMed ID: 14973333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation on activities of hammerhead ribozyme embedded in genomic RNA of hepatitis delta virus].
    Li XJ; Kuang ES; Dai W; Yang FH; Wang M; Wang HS; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):12-5. PubMed ID: 16201462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly improved rescue of rabies virus from cDNA plasmids.
    Ghanem A; Kern A; Conzelmann KK
    Eur J Cell Biol; 2012 Jan; 91(1):10-6. PubMed ID: 21397981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies.
    Price SR; Ito N; Oubridge C; Avis JM; Nagai K
    J Mol Biol; 1995 Jun; 249(2):398-408. PubMed ID: 7540213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Acting 5' hammerhead ribozyme optimization for in vitro transcription of highly structured RNAs.
    Meyer M; Masquida B
    Methods Mol Biol; 2014; 1086():21-40. PubMed ID: 24136596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity purification of in vitro transcribed RNA with homogeneous ends using a 3'-ARiBo tag.
    Di Tomasso G; Salvail-Lacoste A; Bouvette J; Omichinski JG; Legault P
    Methods Enzymol; 2014; 549():49-84. PubMed ID: 25432744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo RNA transcript-releasing plasmid possessing a universal pseudo-terminator by means of artificial ribozymes.
    Ohme-Takagi M; Shinshi H; Oda M; Uchimaru T; Nishikawa S; Taira K
    Nucleic Acids Symp Ser; 1990; (22):49-50. PubMed ID: 1714571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of templates for production of ribozymes and substrates.
    Gaur RK; Krupp G
    Methods Mol Biol; 1997; 74():69-78. PubMed ID: 9204422
    [No Abstract]   [Full Text] [Related]  

  • 18. Human hepatitis delta virus RNA subfragments contain an autocleavage activity.
    Wu HN; Lin YJ; Lin FP; Makino S; Chang MF; Lai MM
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1831-5. PubMed ID: 2648383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
    Liu J; Timmers AM; Lewin AS; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.